Selective M1 muscarinic agonists as potential disease modifiers for Alzheimer disease (AD)

被引:0
作者
Fisher, A
Brandeis, R
Pittel, Z
Inestrosa, N
Farias, G
Sparks, DL
Hartmann, T
Bons, N
机构
[1] Israel Inst Biol Res, IL-70450 Ness Ziona, Israel
[2] Univ Catholica, Santiago, Chile
[3] Sun Hlth Res Ctr, Sun City, AZ USA
[4] Heidelberg Univ, Heidelberg, Germany
[5] EPHE, Montpellier, France
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
34
引用
收藏
页码:S10 / S10
页数:1
相关论文
共 9 条
[1]  
BEACH, 2003, CURR MED CHEM IMMUN, V3, P1233
[2]  
FISHER, 2002, J NEURAL TRANSM-SUPP, V62, P189
[3]   Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease [J].
Hock, C ;
Maddalena, A ;
Raschig, A ;
Müller-Spahn, F ;
Eschweiler, G ;
Hager, K ;
Heuser, I ;
Hampel, H ;
Müller-Thomsen, T ;
Oertel, W ;
Wienrich, M ;
Signorell, A ;
Gonzalez-Agosti, C ;
Nitsch, RM .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (01) :1-6
[4]  
Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO
[5]  
2-J
[6]   Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors [J].
Parnetti, L ;
Amici, S ;
Lanari, A ;
Romani, C ;
Antognelli, C ;
Andreasen, N ;
Minthon, L ;
Davidsson, P ;
Pottel, H ;
Blennow, K ;
Gallai, V .
NEUROLOGICAL SCIENCES, 2002, 23 (Suppl 2) :S95-S96
[7]   Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs [J].
Perry, EK ;
Kilford, L ;
Lees, AJ ;
Burn, DJ ;
Perry, RH .
ANNALS OF NEUROLOGY, 2003, 54 (02) :235-238
[8]   Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease:: A 26-week randomized, placebo-controlled, double-blind trial [J].
Simons, M ;
Schwärzler, F ;
Lütjohann, D ;
von Bergmann, K ;
Beyreuther, K ;
Dichgans, J ;
Wormstall, H ;
Hartmann, T ;
Schulz, JB .
ANNALS OF NEUROLOGY, 2002, 52 (03) :346-350
[9]  
SPARKS, 2003, ADPD2003 SEV MAY